Literature DB >> 8546215

Altered neurofilament expression does not contribute to Lewy body formation.

C Bergeron1, C Petrunka, L Weyer, M S Pollanen.   

Abstract

Lewy bodies (LBs) are cytoskeletal alterations found in several neurodegenerative disorders. Although neurofilaments are the main constituent of the LB, the precise mechanisms that underlie their formation remain speculative. To examine the pathogenesis of this inclusion, we measured the mRNA level of the low molecular weight neurofilament subunit in the nigral dopaminergic neurons of patients with LB disorders and neurologically normal controls. We found a small but significant decrease in the mean mRNA values in the LB group as compared with controls. However, a comparison of LB-bearing and non-LB-bearing neurons on the same section showed no significant difference between these two neuronal populations. We conclude that altered neurofilament expression is not a major contributory event in the pathogenesis of the LB. The decrease in neurofilament mRNA expression observed in the overall nigral dopaminergic neuronal population of LB disorders probably represents a nonspecific response to neuronal injury independent of LB formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546215      PMCID: PMC1861588     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Lewy bodies in Alzheimer disease--one or two diseases?

Authors:  C Bergeron; M Pollanen
Journal:  Alzheimer Dis Assoc Disord       Date:  1989       Impact factor: 2.703

2.  Characterization of messenger RNA from the cerebral cortex of control and Alzheimer-afflicted brain.

Authors:  J G Guillemette; L Wong; D R Crapper McLachlan; P N Lewis
Journal:  J Neurochem       Date:  1986-09       Impact factor: 5.372

3.  An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination.

Authors:  C Bancher; H Lassmann; H Budka; K Jellinger; I Grundke-Iqbal; K Iqbal; G Wiche; F Seitelberger; H M Wisniewski
Journal:  J Neuropathol Exp Neurol       Date:  1989-01       Impact factor: 3.685

4.  Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex.

Authors:  A W Clark; C A Krekoski; I M Parhad; D Liston; J P Julien; D I Hoar
Journal:  Ann Neurol       Date:  1989-04       Impact factor: 10.422

5.  Sporadic lower motor neuron disease with Lewy body-like inclusions: a new subgroup?

Authors:  T Kato; T Katagiri; A Hirano; H Sasaki; S Arai
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  The structure of a human neurofilament gene (NF-L): a unique exon-intron organization in the intermediate filament gene family.

Authors:  J P Julien; F Grosveld; K Yazdanbaksh; D Flavell; D Meijer; W Mushynski
Journal:  Biochim Biophys Acta       Date:  1987-06-06

7.  Neuronal gene expression in aluminum myelopathy.

Authors:  I M Parhad; C A Krekoski; A Mathew; P M Tran
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

8.  Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles.

Authors:  P G Galloway; I Grundke-Iqbal; K Iqbal; G Perry
Journal:  J Neuropathol Exp Neurol       Date:  1988-11       Impact factor: 3.685

9.  Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies.

Authors:  S Love; T Saitoh; S Quijada; G M Cole; R D Terry
Journal:  J Neuropathol Exp Neurol       Date:  1988-07       Impact factor: 3.685

10.  Aluminum neurotoxicity: altered expression of cytoskeletal genes.

Authors:  N A Muma; J C Troncoso; P N Hoffman; E H Koo; D L Price
Journal:  Brain Res       Date:  1988-04       Impact factor: 3.252

View more
  4 in total

1.  Altered neurofilament expression does not contribute to Lewy body formation.

Authors:  W D Hill
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

Review 2.  The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.

Authors:  Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol       Date:  2010-06-20       Impact factor: 17.088

Review 3.  Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?

Authors:  Walter J Schulz-Schaeffer
Journal:  Biomolecules       Date:  2015-07-16

Review 4.  Dementia with Lewy bodies: an update and outlook.

Authors:  Tiago Fleming Outeiro; David J Koss; Daniel Erskine; Lauren Walker; Marzena Kurzawa-Akanbi; David Burn; Paul Donaghy; Christopher Morris; John-Paul Taylor; Alan Thomas; Johannes Attems; Ian McKeith
Journal:  Mol Neurodegener       Date:  2019-01-21       Impact factor: 14.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.